Brenus Pharma
Latest round
- Series A
Last raised
- Jul 2026
Total raised
- $37M
Investors
- 10
About Brenus Pharma
Based in Lyon, France, and founded in 2014 by co-founders Benoit Pinteur and Jacques Gardette, Brenus Pharma operates as a biotechnology company developing next-generation in vivo immunotherapies for solid tumors. Leveraging its proprietary Stimulated-Ghost-Cells (SGC) platform, the company develops tumor antigen-focused immunotherapies designed to reproduce tumor heterogeneity, reveal resistance mechanisms, and stimulate anti-tumor immune responses. Brenus Pharma develops next-generation in vivo cancer immunotherapies for solid tumors using its proprietary Stimulated-Ghost-Cells (SGC) platform. The company generates off-the-shelf, tumor antigen-focused immunotherapies designed to reproduce tumor heterogeneity, reveal resistance mechanisms, and stimulate a multi-specific immune response against cancer cells. Its lead product candidate, STC-1010, is being developed for colorectal cancer, with additional programs targeting other solid tumors. Brenus Pharma intends to use the proceeds to advance its lead candidate, STC-1010 (NCT06934538), through Phase I clinical development while further expanding the application of its STC platform across multiple hard-to-treat solid tumour indications.
Who invested in Brenus Pharma
10 investors across 2 rounds
See all investors in Brenus Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Brenus Pharma
Who invested in Brenus Pharma?
Brenus Pharma has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Brenus Pharma raised?
Brenus Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Brenus Pharma last raise money?
Brenus Pharma's most recent round on record is a Series A, in Jul 2026.
What does Brenus Pharma do?
Based in Lyon, France, and founded in 2014 by co-founders Benoit Pinteur and Jacques Gardette, Brenus Pharma operates as a biotechnology company developing next-generation in vivo immunotherapies for solid tumors.
Where is Brenus Pharma headquartered?
Brenus Pharma is headquartered in Lyon, France.
Which VCs invest in companies like Brenus Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Brenus Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Brenus Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.